Answers are grounded in this paper and cite their sources.
In a real-world setting, female sex was found to be associated with a hyper-response to GLP-1 analogue therapy for obesity management. Other clinical factors evaluated, including diabetes status, were not associated with the response. Future research should assess additional variables and support the development of novel biomarkers that are associated with weight loss response.
No takes yet. Share an insight, caveat, or question.
Squire et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: